Literature DB >> 3408682

Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: a histological and immunohistological study.

H P Horny1, E Kaiserling.   

Abstract

Systemic mastocytosis (SM) can be regarded as a tumorous proliferation of tissue mast cells (TMC) involving various organs, particularly the bone marrow. The infiltrates, however, are by no means composed exclusively of TMC, but also contain eosinophils and lymphocytes. The varying composition of the TMC infiltrates and the immunohistological characteristics of the lymphatic cells were the main subjects of investigation in this study. Three different types of bone marrow infiltrates could be identified: (1) A pure mastocytic infiltrate. (2) A mixed mastocytic/lymphocytic infiltrate. (3) A predominantly lymphocytic infiltrate containing loosely-scattered TMC. The mixed mastocytic/lymphocytic infiltrate seems to be a unique finding confined to the bone marrow in cases of SM, and is not detected in this conformation in other tissue sites normally involved in SM (spleen, liver, lymph nodes and skin), nor in cases of malignant mastocytosis. The lymphoid cells could be identified immunohistologically as being an admixture of T lymphocytes and B lymphocytes, while NK cells were virtually absent from the composite nodules. The TMC reacted strongly with antibodies (monoclonal or polyclonal) against vimentin, common leucocyte antigen, lysozyme, alpha 1-antichymotrypsin and alpha 1-antitrypsin, but were negative with a variety of other antibodies tested (UCHL1, MB1, Ki-B3, Leu-7, KL1, desmin, S-100 protein, F VIII-related antigen and chromogranin A).

Entities:  

Mesh:

Year:  1988        PMID: 3408682     DOI: 10.1111/j.1365-2141.1988.tb02397.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

Review 1.  Mastocytosis and disorders of mast cell proliferation.

Authors:  Joanne K Simpson; Dean D Metcalfe
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

2.  Immunophenotyping of acute lymphoblastic leukaemia in routinely processed bone marrow biopsy specimens.

Authors:  B Toth; M Wehrmann; E Kaiserling; H P Horny
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

3.  Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis.

Authors:  S Seitz; F Barvencik; T Koehne; M Priemel; P Pogoda; J Semler; H Minne; M Pfeiffer; J Zustin; K Püschel; C Eulenburg; T Schinke; M Amling
Journal:  Osteoporos Int       Date:  2013-02-23       Impact factor: 4.507

4.  Chromogranin A is not a biomarker of mastocytosis.

Authors:  Pahul Hanjra; Chyi-Chia R Lee; Irina Maric; Melody Carter; Ana Olivera; Dean D Metcalfe; Hirsh D Komarow
Journal:  J Allergy Clin Immunol Pract       Date:  2017-10-13

5.  Acute lymphoblastic leukaemia: correlation between morphological/immunohistochemical and molecular biological findings in bone marrow biopsy specimens.

Authors:  S M Kröber; A Greschniok; E Kaiserling; H P Horny
Journal:  Mol Pathol       Date:  2000-04

6.  Neoplastic human tissue mast cells express the adhesion molecule CD44/HCAM.

Authors:  H P Horny; D M Menke; E Kaiserling
Journal:  Virchows Arch       Date:  1996-10       Impact factor: 4.064

7.  Myelosarcomatosis of the skin preceding leukemic generalization of acute myelomonocytic leukemia.

Authors:  C P Muller; A Ziegler; B Steinke; H P Horny; H D Waller
Journal:  Blut       Date:  1989-03

8.  QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimens.

Authors:  H P Horny; M Wehrmann; H U Schlicker; A Eichstaedt; M R Clemens; E Kaiserling
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

9.  Lectin histochemistry of human bone marrow: investigation of trephine biopsy specimens in normal and reactive states and neoplastic disorders.

Authors:  U Schumacher; H P Horny; U Welsch; E Kaiserling
Journal:  Histochem J       Date:  1991-05

10.  Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immunohistochemical and molecular findings on routinely processed bone marrow biopsy specimens.

Authors:  H-P Horny; K Lange; K Sotlar; P Valent
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.